The wins are real but quiet. If you were running low, you fall asleep about 17 minutes faster 1. If your blood pressure was already high on medication, it drops a few points over three months; if it was normal, nothing happens 2. Magnesium is probably effective for migraine prevention 3, and beats placebo on depression scores 4. The through-line: bigger benefit if you were short, little if you weren't. It does not, for the record, fix the leg cramps most people take it for 5.
Food first, then match the form to the job. Adult target: 420 mg/day for men, 320 mg/day for women 6. An ounce of pumpkin seeds is 156 mg, a cooked cup of spinach about the same. If your plate lands near the target, skip the pill. If it doesn't, the form decides what you get:
What you'll notice, and when.
- First two weeks: if you were low, you're out faster at night 7; the morning bathroom visit lands on time.
- One to three months: high blood pressure eases a few points on your home cuff 2; a migraine month may have a day or two fewer lost 3.
- Across the years: the part you can't feel. Higher lifetime intake tracks with less stroke, heart failure, and early death 8. If your diet already hit the target, the honest payoff is small.
The fine print — when to skip it, and what people get wrong
"My blood test was normal." Only about 1% of your magnesium is in blood; kidneys hold that number steady by draining bone, so a normal serum result doesn't rule out a shortage 9.
"More is better." The supplemental cap is 350 mg/day from pills; the limit is diarrhoea, not toxicity 6.
Skip pills if your kidneys are impaired. Magnesium piles up and can slow the heart; with chronic kidney disease, ask a nephrologist first 6. Food is fine.
Magnesium blocks certain antibiotics and osteoporosis bisphosphonates; separate those doses by two to four hours. On a proton pump inhibitor plus a diuretic, you may need blood monitoring rather than a supplement alone 10.
Why it "didn't work": wrong form for the goal; underdosed (a "500 mg" pill is often ~100 mg elemental); already replete; or something draining you faster than the pill refills, like PPIs plus a diuretic, or heavy alcohol 10.
- 1Mah J, Pitre T (2021). Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis. BMC Complementary Medicine and Therapies. link
- 2Argeros Z, Xu X, Bhandari B, Harris K, Toutz RM, Schutte AE (2025). Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Hypertension. link
- 3Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E (2012). Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults (AAN/AHS). Neurology. link
- 4Moabedi M, Aliakbari M, Erfanian S, Milajerdi A (2023). Magnesium supplementation beneficially affects depression in adults with depressive disorder: a systematic review and meta-analysis of randomized clinical trials. Frontiers in Psychiatry. link
- 5Garrison SR, Korownyk CS, Kolber MR, Allan GM, Musini VM, Sekhon RK, Dugré N (2020). Magnesium for skeletal muscle cramps. Cochrane Database of Systematic Reviews. link
- 6NIH Office of Dietary Supplements (2022). Magnesium — Fact Sheet for Health Professionals. link
- 7Held K, Heß A, Spannagel M et al. (2025). Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial. Nature and Science of Sleep. link
- 8Fang X, Wang K, Han D, He X, Wei J, Zhao L, Imam MU, Ping Z, Li Y, Xu Y, Min J, Wang F (2016). Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies. BMC Medicine. link
- 9Workinger JL, Doyle RP, Bortz J (2018). Challenges in the Diagnosis of Magnesium Status. Nutrients. link
- 10Kieboom BC, Kiefte-de Jong JC, Eijgelsheim M, Franco OH, Kuipers EJ, Hofman A, Zietse R, Stricker BH, Hoorn EJ (2015). Proton Pump Inhibitors and Hypomagnesemia in the General Population: A Population-Based Cohort Study. American Journal of Kidney Diseases. link
დაკავშირებული სახელმძღვანელოში (17)
- — The same magnesium that loosens stool at high doses — citrate or oxide — is a genuinely useful tool for sluggish bowels.
- — Magnesium is rated probably-effective for migraine prevention — a cheap first thing to try if you get them.
- — If your legs crawl at night, low magnesium is one of the checkable causes — worth a trial before stronger drugs.
- — Some of the magnesium in whole grains and legumes stays locked up by phytic acid; soaking or fermenting frees it.
- — Long-term acid-blocker use is a recognized cause of low magnesium; if you're on a PPI for years, test it.
- — If you're eyeing ashwagandha for sleep, plain magnesium is the cheaper, better-proven first move.
- — Magnesium is one of the low-cost migraine preventives people try before prescription CGRP inhibitors.
- — Boron is a quiet partner here — it slows how fast magnesium leaves the body.
- — Magnesium pairs with CoQ10 as the evidence-backed supplement duo for cutting migraine frequency.
- — Magnesium is one leg of the electrolyte balance that the Western diet runs short on.
- — Soaking in Epsom salt won't meaningfully raise your magnesium; if you're low, that's a job for diet or a cheap pill, not a float.
- — If you're trialling magnesium for blood pressure, home readings are how you'll know if it's working.
- — Potassium and magnesium travel together — low magnesium makes it hard for your body to hold onto potassium no matter how much you eat.
- — Magnesium is one of the five shelf staples here — modest, real, and cheaper bought on its own.
- — Your body needs magnesium to activate vitamin D, so a magnesium gap can blunt what your D supplement actually does.
- — K2, vitamin D, and magnesium are the crew that decides where calcium ends up. Magnesium helps activate the D that K2 then directs.
- — Reverse osmosis strips the magnesium out of your water; remineralizing puts a slice of your daily magnesium back, alongside food or a supplement.
Magnesium
Generic citrate or glycinate costs under $15/month; even branded forms stay under $30/month. L-threonate at $30–60/month is the outlier and not necessary for the main benefits.
One pill, once a day. Trivial.
Multiple meta-analyses across multiple endpoints — 38-RCT BP meta-analysis in Hypertension (Argeros et al. 2025), AAN/AHS Level B for migraine (Holland et al. 2012), dose-response mortality cohorts (Fang et al. 2016; Bagheri et al. 2022), 18-RCT diabetes meta-analysis (Veronese et al. 2016). Not a 5 because Cochrane found magnesium ineffective for idiopathic muscle cramps (Garrison et al. 2020), sleep evidence is graded low-certainty by GRADE (Mah & Pitre 2021), and form-specific head-to-head bioavailability data is sparse.
Multiple endpoints land inside weeks: faster sleep onset by ~17 min in older deficient adults (Mah & Pitre 2021), modest BP reduction (−2.8/−2.1 mmHg pooled across 38 RCTs in Argeros et al. 2025 — larger in hypertensives), reduced migraine frequency at AAN/AHS Level B (Holland et al. 2012), and dose-dependent bowel-softening from citrate / oxide forms. Effect size is meaningful for the deficient subgroup, smaller for the already-replete.
Dose-response meta-analyses of >1M participants show inverse associations between dietary magnesium intake and stroke, heart failure, type 2 diabetes, and all-cause mortality, with greatest risk reduction between 150–400 mg/day (Fang et al. 2016; Bagheri et al. 2022). Observational and confounded by overall diet quality, but biological plausibility (BP, glucose, arrhythmia mechanisms) and replication make the signal robust.
Pooled 17.4-minute reduction in sleep onset latency in older adults with insomnia (Mah & Pitre 2021); modest improvements in Insomnia Severity Index and sleep efficiency in the 155-subject Held et al. 2025 bisglycinate RCT (effect size Cohen's d ≈ 0.2). Mechanism (NMDA antagonism + GABA-A positive modulation) is consistent. Real but modest signal, largest in deficient older populations.
Meta-analysis of 7 RCTs in adults with depressive disorder (n=325) showed SMD −0.92 on depression scores (Moabedi et al. 2023). Anxiety signals exist but are small and heterogeneous (Boyle et al. 2017). Evidence suggestive rather than settled; effect appears strongest where baseline magnesium status is poor.
Indirect long-term contribution via improved sleep architecture, lower vascular stress, and modest inflammation reduction; no direct cosmetic mechanism. Not a reason to take it.
Subjective energy gains reported when deficiency is corrected, but no direct daily-vitality mechanism and no consistent trial signal in adequately-replete adults. Some indirect lift via improved sleep onset and reduced muscle tension.
Standard magnesium forms (glycinate, citrate, oxide) show no consistent cognitive effect. The L-threonate form has small early human trials reporting working- and episodic-memory improvements (Danielson et al. 2022; Slutsky et al. 2010 in rats), but trials are small, short, and industry-affiliated — signal is form-specific and preliminary.